Request for Covid-19 Impact Assessment of this Report

Healthcare

Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Growth 2022-2028

  • LP 4964918
  • 94 Pages
  • June 2022
  • Healthcare
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of T-Cell & NK-Cell Engaging Bispecific Antibodies will have significant change from previous year. According to our (LP Information) latest study, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size is USD million in 2022 from USD 461.7 million in 2021, with a change of % between 2021 and 2022. The global T-Cell & NK-Cell Engaging Bispecific Antibodies market size will reach USD 5518 million in 2028, growing at a CAGR of 42.5% over the analysis period 2022-2028.

The United States T-Cell & NK-Cell Engaging Bispecific Antibodies market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global T-Cell & NK-Cell Engaging Bispecific Antibodies market, reaching US$ million by the year 2028. As for the Europe T-Cell & NK-Cell Engaging Bispecific Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main T-Cell & NK-Cell Engaging Bispecific Antibodies players cover Amgen, Immunocore, Johnson & Johnson, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of T-Cell & NK-Cell Engaging Bispecific Antibodies market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

T-Cell Engagers

NK-Cell Engagers

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hematological Cancers

Solid Tumors

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Amgen

Immunocore

Johnson & Johnson

Roche

Pfizer

AbbVie

MacroGenics

Regeneron

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for T-Cell & NK-Cell Engaging Bispecific Antibodies by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for T-Cell & NK-Cell Engaging Bispecific Antibodies by Country/Region, 2017, 2022 & 2028

2.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type

2.2.1 T-Cell Engagers

2.2.2 NK-Cell Engagers

2.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type

2.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

2.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Market Share by Type (2017-2022)

2.3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Type (2017-2022)

2.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application

2.4.1 Hematological Cancers

2.4.2 Solid Tumors

2.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application

2.5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Market Share by Application (2017-2022)

2.5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Market Share by Application (2017-2022)

2.5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Application (2017-2022)

3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Company

3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Breakdown Data by Company

3.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales by Company (2020-2022)

3.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Company (2020-2022)

3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Revenue by Company (2020-2022)

3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2022)

3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Company (2020-2022)

3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Company

3.4 Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Location Distribution

3.4.2 Players T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for T-Cell & NK-Cell Engaging Bispecific Antibodies by Geographic Region

4.1 World Historic T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Geographic Region (2017-2022)

4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales by Geographic Region (2017-2022)

4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Revenue by Geographic Region

4.2 World Historic T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country/Region (2017-2022)

4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales by Country/Region (2017-2022)

4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Revenue by Country/Region

4.3 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth

4.4 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth

4.5 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth

4.6 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth

5 Americas

5.1 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country

5.1.1 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022)

5.1.2 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022)

5.2 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type

5.3 Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region

6.1.1 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2017-2022)

6.1.2 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2017-2022)

6.2 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type

6.3 APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies by Country

7.1.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022)

7.1.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022)

7.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type

7.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies by Country

8.1.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022)

8.1.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022)

8.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type

8.3 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies

10.3 Manufacturing Process Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies

10.4 Industry Chain Structure of T-Cell & NK-Cell Engaging Bispecific Antibodies

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors

11.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Customer

12 World Forecast Review for T-Cell & NK-Cell Engaging Bispecific Antibodies by Geographic Region

12.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Forecast by Region

12.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecast by Region (2023-2028)

12.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecast by Type

12.7 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 Immunocore

13.2.1 Immunocore Company Information

13.2.2 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Immunocore Main Business Overview

13.2.5 Immunocore Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Roche

13.4.1 Roche Company Information

13.4.2 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Roche Main Business Overview

13.4.5 Roche Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 AbbVie

13.6.1 AbbVie Company Information

13.6.2 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AbbVie Main Business Overview

13.6.5 AbbVie Latest Developments

13.7 MacroGenics

13.7.1 MacroGenics Company Information

13.7.2 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MacroGenics Main Business Overview

13.7.5 MacroGenics Latest Developments

13.8 Regeneron

13.8.1 Regeneron Company Information

13.8.2 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

13.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Regeneron Main Business Overview

13.8.5 Regeneron Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of T-Cell Engagers

Table 4. Major Players of NK-Cell Engagers

Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2017-2022) & (K Units)

Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2017-2022) & ($ million)

Table 8. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2017-2022)

Table 9. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2017-2022) & (K Units)

Table 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Table 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2017-2022)

Table 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2017-2022)

Table 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2020-2022) & (K Units)

Table 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Company (2020-2022)

Table 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2020-2022) ($ Millions)

Table 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Company (2020-2022)

Table 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Producing Area Distribution and Sales Area

Table 21. Players T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered

Table 22. T-Cell & NK-Cell Engaging Bispecific Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share Geographic Region (2017-2022)

Table 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country/Region (2017-2022)

Table 31. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022) & (K Units)

Table 34. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2017-2022)

Table 35. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2017-2022)

Table 37. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2017-2022) & (K Units)

Table 38. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

Table 39. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2017-2022) & (K Units)

Table 40. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Table 41. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2017-2022) & (K Units)

Table 42. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2017-2022)

Table 43. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2017-2022)

Table 45. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2017-2022) & (K Units)

Table 46. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

Table 47. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2017-2022) & (K Units)

Table 48. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Table 49. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022) & (K Units)

Table 50. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2017-2022)

Table 51. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2017-2022)

Table 53. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2017-2022) & (K Units)

Table 54. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

Table 55. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2017-2022) & (K Units)

Table 56. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of T-Cell & NK-Cell Engaging Bispecific Antibodies

Table 66. Key Market Challenges & Risks of T-Cell & NK-Cell Engaging Bispecific Antibodies

Table 67. Key Industry Trends of T-Cell & NK-Cell Engaging Bispecific Antibodies

Table 68. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List

Table 71. T-Cell & NK-Cell Engaging Bispecific Antibodies Customer List

Table 72. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Forecast by Region

Table 74. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share Forecast by Type (2023-2028)

Table 86. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share Forecast by Application (2023-2028)

Table 90. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share Forecast by Application (2023-2028)

Table 92. Amgen Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 93. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 94. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Amgen Main Business

Table 96. Amgen Latest Developments

Table 97. Immunocore Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 98. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 99. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Immunocore Main Business

Table 101. Immunocore Latest Developments

Table 102. Johnson & Johnson Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 103. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 104. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Johnson & Johnson Main Business

Table 106. Johnson & Johnson Latest Developments

Table 107. Roche Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 108. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 109. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Roche Main Business

Table 111. Roche Latest Developments

Table 112. Pfizer Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 113. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 114. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Pfizer Main Business

Table 116. Pfizer Latest Developments

Table 117. AbbVie Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 118. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 119. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. AbbVie Main Business

Table 121. AbbVie Latest Developments

Table 122. MacroGenics Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 123. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 124. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. MacroGenics Main Business

Table 126. MacroGenics Latest Developments

Table 127. Regeneron Basic Information, T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 128. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered

Table 129. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Regeneron Main Business

Table 131. Regeneron Latest Developments

List of Figures

Figure 1. Picture of T-Cell & NK-Cell Engaging Bispecific Antibodies

Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of T-Cell Engagers

Figure 10. Product Picture of NK-Cell Engagers

Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type in 2021

Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2017-2022)

Figure 13. T-Cell & NK-Cell Engaging Bispecific Antibodies Consumed in Hematological Cancers

Figure 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Hematological Cancers (2017-2022) & (K Units)

Figure 15. T-Cell & NK-Cell Engaging Bispecific Antibodies Consumed in Solid Tumors

Figure 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Solid Tumors (2017-2022) & (K Units)

Figure 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

Figure 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application in 2021

Figure 19. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market by Company in 2021 ($ Million)

Figure 20. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Company in 2021

Figure 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Geographic Region in 2021

Figure 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2017-2022)

Figure 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country/Region in 2021

Figure 25. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2017-2022 (K Units)

Figure 26. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2017-2022 ($ Millions)

Figure 27. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2017-2022 (K Units)

Figure 28. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2017-2022 ($ Millions)

Figure 29. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2017-2022 (K Units)

Figure 30. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2017-2022 ($ Millions)

Figure 33. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country in 2021

Figure 34. Americas T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country in 2021

Figure 35. United States T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region in 2021

Figure 40. APAC T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Regions in 2021

Figure 41. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 45. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country in 2021

Figure 48. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country in 2021

Figure 49. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 50. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country in 2021

Figure 55. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country in 2021

Figure 56. Egypt T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies in 2021

Figure 62. Manufacturing Process Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies

Figure 63. Industry Chain Structure of T-Cell & NK-Cell Engaging Bispecific Antibodies

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370